Skip to main content
Clinical Trials/NCT03975751
NCT03975751
Completed
Not Applicable

A Survey on the Practice of Sedation and Analgesia Among Patients With Severe Brain Injury in China: a Prospective Observational Study

Capital Medical University1 site in 1 country387 target enrollmentJanuary 8, 2019

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Intensive Care Unit
Sponsor
Capital Medical University
Enrollment
387
Locations
1
Primary Endpoint
Performance of sedation assessment
Status
Completed
Last Updated
6 years ago

Overview

Brief Summary

Sedation and analgesia is necessary management for patients in the intensive care units. The high-level studies of sedation and analgesia in China are still deficient, especially in patients with brain injuries who even have been excluded from the relevant studies.

Detailed Description

Sedation and analgesia is necessary management for patients in the intensive care units. The high-level studies of sedation and analgesia in China are still deficient, especially in patients with brain injuries who even have been excluded from the relevant studies. In the present study, a multicenter, 1-day point cross-sectional study about the sedation and analgesia among patients in China, particularly brain-injured will be investigated. The objectives are to investigate sedation and analgesia among patients in China and to compare sedation and analgesia between brain injuries and other patients.

Registry
clinicaltrials.gov
Start Date
January 8, 2019
End Date
March 9, 2019
Last Updated
6 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
Capital Medical University
Responsible Party
Principal Investigator
Principal Investigator

Jian-Xin Zhou

Professor

Capital Medical University

Eligibility Criteria

Inclusion Criteria

  • All adult patients admitted to the participating ICUs on the investigation day

Exclusion Criteria

  • Age under 18 years
  • Less than 24 hours of ICU stay before screening
  • Taking part in other studies

Outcomes

Primary Outcomes

Performance of sedation assessment

Time Frame: The previous 24 hours prior to the on-site investigation

The percentage of patients receiving sedation assessment

Performance of pain assessment

Time Frame: The previous 24 hours prior to the on-site investigation

The percentage of patients receiving pain assessment

Secondary Outcomes

  • ICU mortality(Within 60 days after on-site investigation)
  • Use of analgesics(The previous 24 hours prior to the on-site investigation)
  • Use of sedatives(The previous 24 hours prior to the on-site investigation)
  • Hospital mortality(Within 60 days after on-site investigation)

Study Sites (1)

Loading locations...

Similar Trials